CoChat
Sign Up
Cited by 799Smoking Behavior and CessationChronic Obstructive Pulmonary Disease (COPD) ResearchGlobal Cancer Incidence and Screening

The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK

Open access
Pirie, Kirstin, Peto, Richard, Reeves, Gillian K, Green, Jane, Beral, Valerie·2013·The Lancet
DOI 10.1016/s0140-6736(12)61720-6PMC PMC3547248
Open this paper in CoChat — free accountOpen PDF

Abstract

Background Women born around 1940 in countries such as the UK and USA were the first generation in which many smoked substantial numbers of cigarettes throughout adult life. Hence, only in the 21st century can we observe directly the full effects of prolonged smoking, and of prolonged cessation, on mortality among women in the UK. Methods For this prospective study, 1·3 million UK women were recruited in 1996-2001 and resurveyed postally about 3 and 8 years later. All were followed to Jan 1, 2011, through national mortality records (mean 12 woman-years, SD 2). Participants were asked at entry whether they were current or ex-smokers, and how many cigarettes they currently smoked. Those who were ex-smokers at both entry and the 3-year resurvey and had stopped before the age of 55 years were categorised by the age they had stopped smoking. We used Cox regression models to obtain adjusted relative risks that compared categories of smokers or ex-smokers with otherwise similar never-smokers. Findings After excluding 0·1 million women with previous disease, 1·2 million women remained, with median birth year 1943 (IQR 1938-46) and age 55 years (IQR 52-60). Overall, 6% (66,489/1,180,652) died, at mean age 65 years (SD 6). At baseline, 20% (232,461) were current smokers, 28% (328,417) were ex-smokers, and 52% (619,774) were never-smokers. For 12-year mortality, those smoking at baseline had a mortality rate ratio of 2·76 (95% CI 2·71-2·81) compared with never-smokers, even though 44% (37,240/85,256) of the baseline smokers who responded to the 8-year resurvey had by then stopped smoking. Mortality was tripled, largely irrespective of age, in those still smoking at the 3-year resurvey (rate ratio 2·97, 2·88-3·07). Even for women smoking fewer than ten cigarettes per day at baseline, 12-year mortality was doubled (rate ratio 1·98, 1·91-2·04). Of the 30 most common causes of death, 23 were increased significantly in smokers; for lung cancer, the rate ratio was 21·4 (19·7-23·2). The excess mortality among smokers (in comparison with never-smokers) was mainly from diseases that, like lung cancer, can be caused by smoking. Among ex-smokers who had stopped permanently at ages 25-34 years or at ages 35-44 years, the respective relative risks were 1·05 (95% CI 1·00-1·11) and 1·20 (1·14-1·26) for all-cause mortality and 1·84 (1·45-2·34) and 3·34 (2·76-4·03) for lung cancer mortality. Thus, although some excess mortality remains among these long-term ex-smokers, it is only 3% and 10% of the excess mortality among continuing smokers. If combined with 2010 UK national death rates, tripled mortality rates among smokers indicate 53% of smokers and 22% of never-smokers dying before age 80 years, and an 11-year lifespan difference. Interpretation Among UK women, two-thirds of all deaths of smokers in their 50s, 60s, and 70s are caused by smoking; smokers lose at least 10 years of lifespan. Although the hazards of smoking until age 40 years and then stopping are substantial, the hazards of continuing are ten times greater. Stopping before age 40 years (and preferably well before age 40 years) avoids more than 90% of the excess mortality caused by continuing smoking; stopping before age 30 years avoids more than 97% of it. Funding Cancer Research UK, Medical Research Council.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(12)61720-6

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 15

  1. [2]Jarvis M Trends in sales weighted tar, nicotine, and carbon monoxide yields of UK cigarettes Thorax 56 2001 960 963 11713360 PMC1745981
  2. [3]Peto R Whitlock G Jha P Effects of obesity and smoking on U.S. life expectancy N Engl J Med 362 2010 855 856 20200394
  3. [5]Doll R Peto R Boreham J Wheatley K Gray R Sutherland I Mortality in relation to smoking: 40 years’ observations on male British doctors BMJ 309 1994 901 911 7755693 PMC2541142
  4. [7]Thun MJ Day-Lally CA Calle EE Flanders WD Heath CW Excess mortality in cigarette smokers: changes in a 20-year interval Am J Public Health 85 1995 1223 1230 7661229 PMC1615570
  5. [8]Wald N Nicolaides-Bouman A UK Smoking Statistics 2nd edn. 1991 Oxford University Press Oxford
  6. [9]Kenfield SA Stampfer MJ Rosner BA Colditz GA Smoking and smoking cessation in relation to mortality in women JAMA 299 2008 2037 2047 18460664 PMC2879642
  7. [10]Kenfield SA Wei EK Rosner BA Glynn RJ Stampfer MJ Colditz GA Burden of smoking on cause-specific mortality: application to the Nurses’ Health Study Tob Control 19 2010 248 254 20501499 PMC3050007
  8. [12]The Million Women Study Collaborative Group The Million Women Study: design and characteristics of the study population Breast Cancer Res 1 1999 73 80 11056681 PMC13913
  9. [15]Prospective Studies Collaboration Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies Lancet 373 2009 1083 1096 19299006 PMC2662372
  10. [17]International Agency for Research on Cancer International Agency for Research on Cancer (IARC) monographs on the evaluation of carcinogenic risks to humans. Vol. 100E: a review of human carcinogens: personal habits and indoor combustions 2012 IARC Lyon PMC4781577 23193840
  11. [19]International Agency for Research on Cancer Monographs on the evaluation of carcinogenic risks to humans. Vol. 83: tobacco smoke and involuntary smoking 2004 IARC Lyon PMC4781536 15285078
  12. [20]Thun MJ, Carter BD, Feskanich D, et al. Recent trends in mortality risks associated with active cigarette smoking in the United States. N Engl J Med (in press).
  13. [21]Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Peto R. Direct observation of the hazard of smoking and benefits of stopping in the US during the 21st century: nationally representative prospective cohort study. N Engl J Med (in press). 23343063
  14. [22]Sakata R McGale P Grant EJ Ozasa K Peto R Darby SC The effect of smoking on mortality and life expectancy in Japan BMJ 345 2012 e7093 23100333 PMC3481021
  15. [25]Peto R. Nature, nurture and luck: Richard Peto celebrates Richard Doll, who made sense of the causes of cancer. Oxford Today (Oxford), Michaelmas issue: 13, 2005.

Cited by

Sorted by citations

Authors
Pirie, K., Peto, R., Reeves, G. K., Green, J., & Beral, V.
Affiliations
University of Oxford (GB)
Corresponding author
Pirie, Kirstin
ORCID
Venue
The Lancet
Publisher
Elsevier BV
Published
2013-01
Volume
381
Issue
9861
Pages
133-141
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(12)61720-6
PMC
PMC3547248
OpenAlex
W2137986149
Cited by
799
References
2
Citations by year
2026: 29 · 2025: 36 · 2024: 82 · 2023: 43 · 2022: 59 · 2021: 64 · 2020: 62 · 2019: 54 · 2018: 66 · 2017: 63 · 2016: 53 · 2015: 68 · 2014: 60 · 2013: 56 · 2012: 2
FWCI
39.87
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Cancer Research UK
  • Medical Research Council
  • British Heart Foundation
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords
smoking, women, mortality, smoking cessation, former smokers, never smokers, cardiovascular disease, cancer, lung cancer, breast cancer
MeSH terms
Adult, Age Factors, Aged, Data Collection, Female, United Kingdom, Humans, Middle Aged, Prospective Studies, Risk Factors, Smoking, Socioeconomic Factors, Time Factors, Proportional Hazards Models, Smoking Cessation, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review